Get early access to MenoVida
Join our community, and you can try the app first at a special introductory rate.
We’re building MenoVida with the women who’ll use it. Join our community to be one of the first to try the app and help shape what comes next.
MenoVida will help you keep track of your symptoms through perimenopause and postmenopause. You’ll be able to log what you’re trying, from HRT and medication to supplements and lifestyle changes, and see how your symptoms change over time. It will also create a personalised doctor’s report you can share at your appointments.
We can’t wait to show you.
Your app, your say
Access the app first - Start tracking your symptoms and creating your doctor’s report before our public launch.
Special introductory rate - £2.49 a month for your first 6 months (usually £4.99), after a 30-day free trial.
(For our first 1,000 members. Monthly plan only. Cancel anytime.)
Tell us what you think - What works? What’s missing? Your feedback helps us decide what to build next.
Our monthly newsletter - Hear how the app is coming along, what’s new and how you can get involved.
Early access is for you if you’re:
18 or over
living in the UK. We’re launching here first, so the app will only be available on the UK App Store and Google Play.
in perimenopause or postmenopause, or think you might be. Maybe you’ve started to feel different and are wondering if it’s perimenopause? If so, you’re very welcome.
Outside the UK? You’re still welcome to join our community, and we’ll let you know when MenoVida reaches you.
Supporting someone through perimenopause? Partners, friends, family and colleagues are welcome to join our community too.
Frequently Asked Questions
Still have questions? Check out the FAQ or reach out anytime by emailing hello@menovida.app
-
MenoVida will help you keep track of your symptoms through perimenopause and postmenopause. You’ll be able to log what you’re trying, from HRT and medication to supplements and lifestyle changes, and see how your symptoms change over time.
It will also create a personalised doctor’s report you can share at your appointments. MenoVida won’t diagnose anything. It’s designed to support your conversations with your doctor, not replace them.
-
MenoVida has been in development and is currently being tested by a group of our ambassadors. The version you’ll get is a fully functional first version, ready to use every day. We’ll keep improving it, and your feedback will help us decide what comes next.
-
Membership of our community. You’ll get our monthly newsletter and other emails about news, events and offers.
If you’re in the UK, you’ll also get early access to the app before our public launch. Once you start using it, we’d love to hear what you think. We’ll ask for feedback along the way, but it’s always up to you whether you take part.
-
Anyone aged 18 or over who lives in the UK. We’re launching here first, so the app will only be available on the UK App Store and Google Play.
It’s designed for people in perimenopause or postmenopause, or who think they might be.
-
Yes. Our community is open to anyone aged 18 or over, including partners, friends, family and colleagues. Early access to the app is only for UK members for now.
-
Not to join our community. When the app is ready, you’ll start with a 30-day free trial. You’ll add payment details to start your trial, but you won’t be charged until it ends.
If you decide to keep using it, you’ll pay £2.49 a month for your first 6 months instead of £4.99. That’s our thank you for joining early. This offer is for our first 1,000 members on the monthly plan, and you can cancel anytime, including during your free trial.
-
We’ll email you your download link as soon as early access opens. To make sure it doesn’t end up in your junk folder, please add hello@menovida.app to your contacts.
-
We’re planning for early 2027, once we’ve made improvements based on your feedback. We’ll let you know when we have a date.
-
Use MenoVida before our public launch
A special introductory rate of £2.49 a month for your first 6 months (usually £4.99)
A real say in what we build next